Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies. Providing an international forum for the publication of high-quality original research in hepatology, it is an essential resource for everyone working on normal and abnormal structure and function in the liver and its constituent cells, including clinicians and basic scientists involved in the multi-disciplinary field of hepatology. The journal welcomes articles from all fields of hepatology, which may be published as original articles, brief definitive reports, reviews, mini-reviews, images in hepatology and letters to the Editor.
Liver International促进从基础研究到应用临床研究的肝病科学的各个方面。它为发表高质量的肝脏学原创研究提供了一个国际论坛，是研究肝脏及其组成细胞的正常和异常结构和功能的每个人的重要资源，包括参与肝脏学多学科领域的临床医生和基础科学家。该杂志欢迎来自肝病学所有领域的文章，可以作为原创文章、简短的权威报告、评论、小型评论、肝病学图像和致编辑的信件发表。
Hepatitis C: Is eradication possible?
来源期刊：Liver InternationalDOI：10.1111/liv.14011
Diagnostic and prognostic biomarkers in cholangiocarcinoma
来源期刊：Liver InternationalDOI：10.1111/liv.14090
Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States
来源期刊：Liver InternationalDOI：10.1111/liv.14054
Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States
来源期刊：Liver InternationalDOI：10.1111/liv.14038
Fatigue in chronic liver disease: New insights and therapeutic approaches
来源期刊：Liver InternationalDOI：10.1111/liv.13919
Autoimmune hepatitis: Current and future therapeutic options
来源期刊：Liver InternationalDOI：10.1111/liv.14062
Hepatitis B virus infection and risk of non‐alcoholic fatty liver disease: A population‐based cohort study
来源期刊：Liver InternationalDOI：10.1111/liv.13933
Autoimmune hepatitis exerts a profound, negative effect on health‐related quality of life: A prospective, single‐centre study
来源期刊：Liver InternationalDOI：10.1111/liv.13960
Non‐alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle‐aged adults: The Framingham Study
来源期刊：Liver InternationalDOI：10.1111/liv.14161
Clinicopathological features of He Shou Wu‐induced liver injury: This ancient anti‐aging therapy is not liver‐friendly
来源期刊：Liver InternationalDOI：10.1111/liv.13939
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma
来源期刊：Liver InternationalDOI：10.1111/liv.14094
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study
来源期刊：Liver InternationalDOI：10.1111/liv.14154
Pathways of hepatic and renal damage through non‐classical activation of the renin‐angiotensin system in chronic liver disease
来源期刊：Liver InternationalDOI：10.1111/liv.14272
Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
来源期刊：Liver InternationalDOI：10.1111/liv.14070
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib
来源期刊：Liver InternationalDOI：10.1111/liv.14270
Incidence, predictors and prognosis of genotype 4 hepatitis E related liver failure: A tertiary nested case‐control study
来源期刊：Liver InternationalDOI：10.1111/liv.14221
Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis
来源期刊：Liver InternationalDOI：10.1111/liv.14125
Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono‐infection
来源期刊：Liver InternationalDOI：10.1111/liv.14000
Long‐term outcomes of patients with hepatitis B virus‐related acute on chronic liver failure: An observational cohort study
来源期刊：Liver InternationalDOI：10.1111/liv.14072
P57‐mediated autophagy promotes the efficacy of EGFR inhibitors in hepatocellular carcinoma
来源期刊：Liver InternationalDOI：10.1111/liv.13957
Role of oestrogen and its receptors in HEV‐associated feto‐maternal outcomes
来源期刊：Liver InternationalDOI：10.1111/liv.13928
HCV reinfections after viral clearance among HIV‐positive patients with recent HCV infection in Taiwan
来源期刊：Liver InternationalDOI：10.1111/liv.14199
Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug‐induced liver injury from autoimmune hepatitis
来源期刊：Liver InternationalDOI：10.1111/liv.14195
Prognostic impact of neutrophil‐to‐lymphocyte ratio in cirrhosis: A propensity score matching analysis with a prespecified cut‐point
来源期刊：Liver InternationalDOI：10.1111/liv.14211
miR‐4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation
来源期刊：Liver InternationalDOI：10.1111/liv.14276
Deficiency of canonical Wnt/β‐catenin signalling in hepatic dendritic cells triggers autoimmune hepatitis
来源期刊：Liver InternationalDOI：10.1111/liv.14246
Longitudinal analysis of risk of non‐alcoholic fatty liver disease in adulthood
来源期刊：Liver InternationalDOI：10.1111/liv.13993
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs
来源期刊：Liver InternationalDOI：10.1111/liv.14186
Ideal cardiovascular health metrics and the risk of non‐alcoholic fatty liver disease: A cross‐sectional study in northern China
来源期刊：Liver InternationalDOI：10.1111/liv.14060
Low prevalence of occult hepatitis B virus infection in chronic haemodialysis and kidney transplant patients
来源期刊：Liver InternationalDOI：10.1111/liv.13951
Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult‐to‐manage hydrothorax in cirrhosis
来源期刊：Liver InternationalDOI：10.1111/liv.14200
Dietary fatty acid oxidation is decreased in non‐alcoholic fatty liver disease: A palmitate breath test study
来源期刊：Liver InternationalDOI：10.1111/liv.14309
Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study
来源期刊：Liver InternationalDOI：10.1111/liv.13963
Effect of direct‐acting antivirals on platelet‐associated immunoglobulin G and thrombocytopenia in hepatitis C virus‐related chronic liver disease
来源期刊：Liver InternationalDOI：10.1111/liv.14120
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir
来源期刊：Liver InternationalDOI：10.1111/liv.14017
Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials
来源期刊：Liver InternationalDOI：10.1111/liv.14266
Long‐term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country
来源期刊：Liver InternationalDOI：10.1111/liv.14082
Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient
来源期刊：Liver InternationalDOI：10.1111/liv.14273
Long‐term outcomes of endoscopic treatment for duct‐to‐duct anastomotic strictures after living donor liver transplantation
来源期刊：Liver InternationalDOI：10.1111/liv.14219
Tolerability and effectiveness of generic direct‐acting antiviral drugs in eradication of hepatitis C genotype 4 among Egyptian patients
来源期刊：Liver InternationalDOI：10.1111/liv.14022
The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg‐negative chronic hepatitis B
来源期刊：Liver InternationalDOI：10.1111/liv.14330
Prognostic assessment using a new substaging system for Barcelona clinic liver cancer stage C hepatocellular carcinoma: A nationwide study
来源期刊：Liver InternationalDOI：10.1111/liv.14117
microRNA‐206 modulates the hepatic expression of the organic anion‐transporting polypeptide 1B1
来源期刊：Liver InternationalDOI：10.1111/liv.14212
Comments on ‘Entecavir resistance mutations rtL180M/T184L/M204V combined with rtA200V lead to tenofovir resistance’
来源期刊：Liver InternationalDOI：10.1111/liv.14290
A genome‐wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)
来源期刊：Liver InternationalDOI：10.1111/liv.14177
[18F]‐Fluoro‐2‐deoxy‐D‐galactose positron emission tomography/computed tomography as complementary imaging tool in patients with hepatocellular carcinoma
来源期刊：Liver InternationalDOI：10.1111/liv.14293
Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer
来源期刊：Liver InternationalDOI：10.1111/liv.14323
Injury pattern recognition to discriminate competing causes of liver injury
来源期刊：Liver InternationalDOI：10.1111/liv.14056
Cytocholestasis and Hypercalcemia ‐ what’s the connection?
来源期刊：Liver InternationalDOI：10.1111/liv.14158
Reply to Mantovani: “Causality between non‐alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes”
来源期刊：Liver InternationalDOI：10.1111/liv.14026
